Capital Fund Management (CFM)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.9M | Sell |
50,800
-39,800
| -44% | -$14.2M | 0.08% | 346 |
|
|
2025
Q4 | $29.7M | Sell |
90,600
-57,700
| -39% | -$18.3M | 0.08% | 329 |
|
|
2025
Q3 | $41.9M | Buy |
148,300
+1,600
| +1% | +$464K | 0.11% | 237 |
|
|
2025
Q2 | $41M | Sell |
146,700
-157,800
| -52% | -$44.7M | 0.11% | 252 |
|
|
2025
Q1 | $94.9M | Buy |
304,500
+190,100
| +166% | +$56.1M | 0.27% | 72 |
|
|
2024
Q4 | $29.8M | Sell |
114,400
-94,800
| -45% | -$28.1M | 0.08% | 356 |
|
|
2024
Q3 | $67.4M | Sell |
209,200
-83,500
| -29% | -$27.3M | 0.18% | 150 |
|
|
2024
Q2 | $91.5M | Sell |
292,700
-46,600
| -14% | -$13.7M | 0.27% | 90 |
|
|
2024
Q1 | $96.5M | Buy |
339,300
+125,200
| +58% | +$36.6M | 0.28% | 72 |
|
|
2023
Q4 | $61.7M | Buy |
214,100
+4,800
| +2% | +$1.31M | 0.17% | 146 |
|
|
2023
Q3 | $56.3M | Sell |
209,300
-40,800
| -16% | -$10.2M | 0.19% | 130 |
|
|
2023
Q2 | $55.5M | Buy |
250,100
+117,500
| +89% | +$27.3M | 0.23% | 108 |
|
|
2023
Q1 | $32.1M | Buy |
132,600
+117,700
| +790% | +$28.9M | 0.15% | 174 |
|
|
2022
Q4 | $3.91M | Sell |
14,900
-14,700
| -50% | -$3.94M | 0.03% | 705 |
|
|
2022
Q3 | $6.67M | Sell |
29,600
-500
| -2% | -$121K | 0.05% | 452 |
|
|
2022
Q2 | $7.32M | Buy |
+30,100
| New | +$7.38M | 0.07% | 406 |
|
|
2022
Q1 | – | Sell |
-20,500
| Closed | -$4.61M | – | 1425 |
|
|
2021
Q4 | $4.61M | Buy |
20,500
+3,900
| +23% | +$823K | 0.03% | 672 |
|
|
2021
Q3 | $3.53M | Buy |
+16,600
| New | +$3.82M | 0.03% | 714 |
|
|
2021
Q1 | – | Sell |
-91,500
| Closed | -$21M | – | 1251 |
|
|
2020
Q4 | $21M | Sell |
91,500
-46,000
| -33% | -$10.6M | 0.2% | 125 |
|
|
2020
Q3 | $34.9M | Sell |
137,500
-28,100
| -17% | -$6.96M | 0.43% | 43 |
|
|
2020
Q2 | $39.1M | Sell |
165,600
-134,900
| -45% | -$30.8M | 0.62% | 18 |
|
|
2020
Q1 | $60.9M | Buy |
300,500
+113,000
| +60% | +$24.7M | 0.94% | 7 |
|
|
2019
Q4 | $45.2M | Buy |
187,500
+177,800
| +1,833% | +$39.2M | 0.36% | 65 |
|
|
2019
Q3 | $1.88M | Buy |
+9,700
| New | +$1.86M | 0.02% | 815 |
|
|
2018
Q4 | – | Sell |
-37,600
| Closed | -$7.79M | – | 1817 |
|
|
2018
Q3 | $7.79M | Buy |
37,600
+36,100
| +2,407% | +$7.11M | 0.04% | 586 |
|
|
2018
Q2 | $277K | Sell |
1,500
-18,700
| -93% | -$3.31M | ﹤0.01% | 1813 |
|
|
2018
Q1 | $3.44M | Buy |
20,200
+12,300
| +156% | +$2.26M | 0.02% | 815 |
|
|
2017
Q4 | $1.37M | Sell |
7,900
-3,700
| -32% | -$655K | 0.01% | 1104 |
|
|
2017
Q3 | $2.16M | Buy |
11,600
+2,200
| +23% | +$390K | 0.02% | 751 |
|
|
2017
Q2 | $1.62M | Sell |
9,400
-16,500
| -64% | -$2.68M | 0.01% | 772 |
|
|
2017
Q1 | $4.25M | Sell |
25,900
-5,400
| -17% | -$897K | 0.04% | 536 |
|
|
2016
Q4 | $4.58M | Sell |
31,300
-51,400
| -62% | -$7.74M | 0.04% | 524 |
|
|
2016
Q3 | $13.8M | Buy |
+82,700
| New | +$14M | 0.13% | 213 |
|
|
2016
Q2 | – | Sell |
-37,300
| Closed | -$5.59M | – | 1497 |
|
|
2016
Q1 | $5.59M | Sell |
37,300
-9,900
| -21% | -$1.47M | 0.05% | 400 |
|
|
2015
Q4 | $7.66M | Buy |
47,200
+12,800
| +37% | +$2.01M | 0.08% | 331 |
|
|
2015
Q3 | $4.76M | Sell |
34,400
-89,300
| -72% | -$14.1M | 0.05% | 411 |
|
|
2015
Q2 | $19M | Sell |
123,700
-161,700
| -57% | -$25.9M | 0.24% | 108 |
|
|
2015
Q1 | $45.6M | Buy |
285,400
+88,600
| +45% | +$14M | 0.62% | 21 |
|
|
2014
Q4 | $31.3M | Buy |
196,800
+74,300
| +61% | +$11.6M | 0.37% | 54 |
|
|
2014
Q3 | $17.2M | Buy |
122,500
+32,100
| +36% | +$4.19M | 0.19% | 128 |
|
|
2014
Q2 | $10.7M | Sell |
90,400
-6,200
| -6% | -$718K | 0.11% | 216 |
|
|
2014
Q1 | $11.9M | Sell |
96,600
-62,900
| -39% | -$7.63M | 0.15% | 161 |
|
|
2013
Q4 | $18.2M | Sell |
159,500
-147,700
| -48% | -$16.8M | 0.23% | 75 |
|
|
2013
Q3 | $34.4M | Buy |
307,200
+89,600
| +41% | +$9.72M | 0.48% | 30 |
|
|
2013
Q2 | $21.5M | Buy |
+217,600
| New | +$22.6M | 0.33% | 41 |
|
Other funds holding AMGN
VCM
VPM
Capital Fund Management (CFM)'s AMGN Position: Q1 2026 in Review
Capital Fund Management (CFM) reduced its Amgen (AMGN) stake by 75% in Q1 2026, selling an estimated $13.6M and leaving 12,941 shares worth $4.55M. The position accounts for 0.02% of the portfolio, ranked #937.
Capital Fund Management (CFM) first reported a position in AMGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $87.3M in Q2 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Capital Fund Management (CFM) held 12,941 shares of Amgen worth $4.55M as of Q1 2026.
- Capital Fund Management (CFM) sold 38,187 Amgen shares in Q1 2026, an estimated $13.6M.
- Amgen made up 0.02% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #937 holding.
- Capital Fund Management (CFM) first reported a position in Amgen in Q2 2013 and has held it in 37 quarters since.
- Capital Fund Management (CFM)'s Amgen position peaked at $87.3M in Q2 2019.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.